Overview

Organon & Co. (Organon) is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies...

Open

$0.00

Prior close

$13.69

Today's high

$0.00

Today's low

$0.00

52 Week high

$13.79

52 Week low

$5.69

News

Business Wire • 5 days ago • OGN

Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device

Zacks Investment Research • 10 days ago • OGN

Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know

GlobeNewsWire • 22 days ago • OGN

National Can-RISE Study to Help Close Critical Gaps in Menopause Research

Business Wire • about 1 month ago • OGN

Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability

Zacks Investment Research • about 2 months ago • OGN

Compared to Estimates, Organon (OGN) Q2 Earnings: A Look at Key Metrics